Operates closely with the Chief Business Officer, Chief Technology Officer and Director of Sales & Marketing to support new customer development, technical sales activities and post-sales customer training and support. - Conducts pre-sales technical presentations- Demonstrates products and services- Maintains expert-level knowledge of the Ceres Nanosciences product line- Pro-actively provides post-sales account development support and problem resolution- Provide technical hands-on customer training for new products and methods- Design and execute experiments as part of pilot or proof-of-concept projects to demonstrate Ceres technology to potential customers. - Manage and update Salesforce CRM system with customer notes and issues- Positive customer relationship management- Conference/Trade show attendance to promote Ceres products and capabilities, and identify new opportunities- Technical scientific writing in the form of project proposals, user manuals, internal SOPs, PowerPoint slide presentations, technical reports, marketing collateral (brochures, graphic design, flyers, banners, application notes, abstracts, posters, press releases, website content creation & organization, social media content creation & account management) - Strategic planning and management supporting internal product development efforts from R&D feasibility to product validation efforts, and product launch campaigns.

Scientific Project Management & Product Development:Actively coordinated multiple ongoing immunoassay development projects across different phases of product development, establishing schedule and scope of independently designed and executed experiments.Performed data collection and analysis as well, identified technical solutions to meet project requirements. Prepared technical reports and presentations for project team meetings. Provided strategic assessments for viable options and future steps based on scientific results.Technology Transfer & Process Development:Established quality control criteria and specifications for results and data collection. Facilitated technology transfer from R&D to Manufacturing and Quality Control departments. Planned and executed troubleshooting, optimization and validation experiments in support of new product development work.

National Institutes of Health; Cancer Research Center. Bethesda, MD & Chemical Genomics Center. Rockville, MD. USA.High Throughput Screening for Small Molecule Modulators of LMNA Splicing In HGPS. Coordinated and executed collaborative, interdisciplinary research efforts between NCATS & NIH Cancer Research Center as part of the NCI/JHU Molecular Targets & Drug Discovery Fellowship Program. Designed and developed novel cell-based dual-luciferase reporter assays for 1536 well plate format. Conducted primary high throughput screening of chemical libraries for drug discovery.Dr. Tom Misteli, Principal Investigator.Dr. Jim Inglese, NCATS Collaborator.

Pasteur Institute, Unit for Integrated Mycobacterial Pathogenomics. Paris, FranceConstruction of Mycobacterium smegmatis strain delta RD1. Used TOPO® PCR Cloning to remove the homologous RD1 region of M. smegmatis and to insert the 9.5kb RD1 region of M. tuberculosis to facilitate the study of M. tuberculosis genes without the need of a BSL-3, resulting in months of time saved.Dr. Roland Brosch, Principal Investigator.Dr. Alessandro Cascioferro, Primary Supervisor

Harvard, Department of Immunology and Infectious Diseases, Boston, MAIdentifying Interacting Proteins of the Mycobacterial Cell Wall Remodeling Enzyme, AftB, Through a Yeast Two Hybrid Genetic Screen. Prof. Eric Rubin, Principal Investigator.